-
TROP2-Targeted Antibody-Drug Conjugates Set to Transform NSCLC Treatment Market by 2040 | DelveInsight
10 Sep 2025 22:12 GMT
… Emerging TROP2 ADCs in NSCLC Drugs
Competitive Intelligence Analysis: SWOT … among others.
Antibody Drug Conjugates Market
Antibody Drug Conjugates Market Size, … AbbVie, Genmab, Daiichi Sankyo, AstraZeneca, Astellas, Roche, Pfizer (Seagen), Takeda, Ambrx …
-
Bayer's hot flash drug posts promising results while awaiting FDA nod
10 Sep 2025 18:30 GMT
… researchers also found the drug was safe after participants took … by the Food and Drug Administration, elinzanetant could be … a blockbuster drug in the United States … S. television advertising pushes.
Astellas Chief Commercial and Medical Affairs …
-
Oncology/Cancer Drugs Market | Projected To Reach $274,400.63 Million By 2030
05 Sep 2025 12:53 GMT
… .
2. Targeted therapy drugs: These drugs target specific molecules or … Ag,
• Astrazeneca Plc,
• Astellas Pharma Inc.,
• Bristol-Myers Squibb … strategies.
The global oncology drug market is segmented on … the basis of drug type, indication and region …
-
Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic
04 Sep 2025 00:49 GMT
… advanced programs are cancer drugs addressing known targets but … a different kind of drug discovery company.
Emerging … inhibitors include Revolution Medicines, Astellas Pharma, Amgen, and BridgeBio … Treeline’s approach to drug discovery brings laboratory and …
-
Antiemetic Drugs Market Poised for Strong Growth Amid Rising Cancer & Chemotherapy Cases Worldwide 2025
02 Sep 2025 12:30 GMT
… page?report=antiemetic-drugs-market
Market Segmentation:
By Drug Type: 5-HT3 …
Novartis AG
Bristol-Myers Squibb
Astellas Pharma, Inc.
Eli Lilly and … .
Related Reports:
Antiepileptic Drugs Market
Antifungal Drugs Market
Sai Kiran
DataM …
-
Antibody Drug Conjugates Market Size, Share And Forecast To 2034
02 Sep 2025 17:02 GMT
… ADCs that deliver two different drugs targeting tumors that resist a …
Recent Developments
In May 2025 , Astellas Pharma Inc. and Evopoint Biosciences … see full report on
Antibody Drug Conjugates Market
Full ReportMENAFN02092025004597010339ID1110005956
Legal …
-
Astellas plans further expansion in China
02 Sep 2025 02:06 GMT
… , chief financial officer of Astellas.
"Growth in the … the organizational structure of Astellas China in 2021, establishing … innovations to Chinese patients, Astellas has included China as … the experience to future drugs, enabling China to achieve …
-
Prostate Cancer Pipeline Outlook 2025 - Investigational Therapies, Clinical Trials, Drugs And Companies, Medication, By Phase, By ROA, By MOA Delveinsight
29 Aug 2025 21:11 GMT
… the US Food and Drug Administration cleared its investigational … the company's novel drug-drug conjugate (DDC) platform.
In … the US Food and Drug Administration granted Fast Track … has evolved with established drugs like XTANDI (Astellas/Pfizer) and …
-
Global Anti Fungal Drugs Market Size to Reach USD 21.50 Billion by 2034, Sustained by Steady Growth
22 Aug 2025 13:23 GMT
… awareness of antifungal drugs.
Based on drug class, the … anti-fungal-drugs-market
📊 Market Segmentation
By Drug Class
Azoles … Demand for generic antifungal drugs due to cost-effectiveness … , Inc.
Bayer AG
Astellas Pharma Inc.
Glenmark Pharmaceuticals …